" class="no-js "lang="en-US"> News Archives - Page 265 of 267 - Medtech Alert
Monday, June 29, 2026

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Welsh Startup Antiverse Raises $2m for Antibody Discovery Toolkit

New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its […]

Antiverse Raises £1.4 Million ($2 Million USD) to Advance Its AI Antibody Drug Discovery Platform

Antiverse, a biotechnology company developing a computational antibody drug discovery platform, has raised seed funding […]

Q'Apel Medical raises $22 Million to grow innovative Neurovascular access platform & Scott Huennekens joins Board of Directors

Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device […]

Zocdoc raises $150 million

New York-based digital healthcare marketplace Zocdoc announced $150 million in growth financing from Francisco Partners, a […]

Personal Genome Diagnostics Announces Close of $103 Million Series C Financing

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced the close of […]

Angelini Pharma and Trueblue: a new collaboration gets underway for optimising data-based decision making and analytics

Promoting the development of corporate decision-making process powered by the use of data, KPIs and […]

FDA approves new treatment for adults with relapsed or refractory large-b-cell lymphoma

Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy […]

Honeywell to produce and donate hand sanitizer to support local needs amid Covid-19 pandemic

Honeywell today announced that it is temporarily shifting manufacturing operations at two chemical manufacturing facilities […]

Honeywell and Wolters Kluwer team up to help employees safely return to the workplace

Honeywell and Wolters Kluwer today announced a collaboration to integrate Honeywell’s Industrial Internet of Things […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more